AndreasRuhlmann

Nektar Pharma - possible short squeeze

做多
NASDAQ:NKTR   Nektar Therapeutics
This is a speculative one as counter trend.

Huge volume stepped in around $16 & $20

reuters data on November 28th shows short interest of 18% of the float, and 11 days to cover. The stock hi fresh highs since august and could pressure those short, extending the potential upside

stop below 20 and target 30.





免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。